skip to main content


Physical and Occupational Therapy Helps Non-Hodgkin Skin Lymphoma Patient

Marty Marchak was diagnosed with stage I non-Hodgkin skin lymphoma, which then began his chemotherapy and radiation journey at the U-M Rogel Cancer Center. Fortunately, after his second chemotherapy session in early December 2018, doctors informed Marchak that the treatments worked and that the remaining chemotherapy and radiation could be discontinued. At first, Marchak had no pain or side effects from his treatment except for being more tired than usual. But then, suddenly, unusual symptoms started to appear.

U-M Rogel Cancer Center first in Michigan to offer all FDA approved CAR T-cell therapies

Media contact: Jessica Webster-Sendra734-764-2220 |  Patients may contact Cancer AnswerLine, 800-865-1125

ANN ARBOR, Michigan — With the recently announced FDA approval of Kymriah to treat adults with lymphoma, the University of Michigan Rogel Cancer Center is the first center in Michigan to offer all currently available CAR T-cell therapies.

What cancer patients should know about preserving fertility

Ask Molly Moravek, M.D., why she pursued a career in fertility preservation for cancer patients, and she’ll tell you that it’s because her heart breaks every time she sees a patient who has had her fertility taken from her. It's why she built a program in partnership with Michigan Medicine’s Center for Reproductive Medicine and Rogel Cancer Center that works with patients facing treatment and their oncologists to preserve the patients’ opportunity to have children once they are healthy.

My Other Voice inspired by U-M student’s cancer experience

Just before graduating from the University of Michigan several years ago, Alex Kip was diagnosed with non-Hodgkins lymphoma, threatening to end his career as an actor and playwright. In the course of treatment, Mr. Kip lost his singing voice. After his treatment was completed, Mr. Kip wrote, My Other Voice. The play was inspired by his experiences with lymphoma.